[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
Main Menu
Home::
Journal Information::
Articles Archive::
Guide for Authors::
For Reviewers::
Ethical Statements::
Registration::
Site Facilities::
Contact us::
::
Indexed by
     
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Copyright Policies

 

AWT IMAGE

 

..
Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

..
:: Articles In Press ::
Back to the articles list Back to browse issues page
Comparative In Silico Analysis of Crocetin, Curcumin, and Capsaicin Interactions with the TRPV1 Receptor: Insights into Their Analgesic Potential
Abdorrahim Absalan * , Zahra Absalan , Fereshteh Parto
Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Iran University of Medical Sciences and Health Services, Tehran, Iran , a.r.absalan@gmail.com
Abstract:   (14 Views)
Introduction: Capsaicin, a pungent phytochemical derived from chili peppers, is a therapeutic agent for the treatment of neuropathic pain. In the present study, bioinformatics and computer-aided drug discovery approaches were employed to screen five phytochemicals with putative analgesic properties and identify promising candidates as potential alternatives to capsaicin. Materials and Methods: The three-dimensional (3D) structure of the capsaicin-sensitive transient receptor potential vanilloid 1 (TRPV1) receptor (PDB ID: 8GFA) was retrieved from the Protein Data Bank (PDB), while the structures of the selected phytochemical ligands were obtained from the PubChem database. Ligand–receptor interactions were investigated using Molegro Virtual Docker (version 6). The most promising ligand–receptor complexes were subsequently selected for molecular dynamics simulations to assess their structural stability and the persistence of intermolecular interactions over time. Results: Among the six phytochemicals investigated (curcumin, crocetin, epigallocatechin gallate, hesperidin, avicularin, and capsaicin), crocetin and curcumin emerged as the most promising candidates based on their molecular mass, predicted interactions with TRPV1, and complex stability. Both compounds exhibited more favorable predicted interactions than capsaicin, with crocetin showing particularly favorable binding stability. Conclusion: These findings suggest that curcumin and crocetin are potential candidates for neuropathic pain management, warranting further experimental investigation to confirm their TRPV1-modulating and analgesic effects.
 
Keywords: Nociceptors, Phytochemicals, Drug Design, Molecular Dynamics Simulation
     
Type of Study: Research --- Open Access, CC-BY-NC | Subject: Bioinformatics in Neuroscience
References
1. Koumpouros Y. in Chronic Pain. Unveiling Technological Advancements and Interdisciplinary Solutions for Pain Care. 2025: 37. [DOI:10.4018/979-8-3693-9501-1]
2. Smith ESJ, Lewin GR. Nociceptors: a phylogenetic view. Journal of Comparative Physiology A. 2009; 195(12): 1089-106. [DOI:10.1007/s00359-009-0482-z]
3. Gavva NR. Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV1. Trends in Pharmacological Sciences. 2008; 29(11): 550-7. [DOI:10.1016/j.tips.2008.08.003]
4. Woolf CJ, Ma Q. Nociceptors-noxious stimulus detectors. Neuron. 2007; 55(3): 353-64. [DOI:10.1016/j.neuron.2007.07.016]
5. Nazari-Srenjeh f, ghasemzadeh z. Brain Regions and Neurotransmitter Systems Involved in Stress-Induced Analgesia. The Neuroscience Journal of Shefaye Khatam. 2024; 13(1): 104-15. [DOI:10.61186/shefa.13.1.104]
6. Abbott GW, Manville RW. NaVigating nociceptive neuron signaling pathways to arrive at pain relief. The Journal of pharmacology and experimental therapeutics. 2025; 392(2). [DOI:10.1016/j.jpet.2024.100037]
7. Andrade ACM, Molina Esquivel N, Goldschmied Rossel F, Benso B. TRPV1-target drugs for the treatment of orofacial pain. Frontiers in Pharmacology. 2025; 16: 1568109. [DOI:10.3389/fphar.2025.1568109]
8. Mansoor SE, Lü W, Oosterheert W, Shekhar M, Tajkhorshid E, Gouaux E. X-ray structures define human P2X3 receptor gating cycle and antagonist action. Nature. 2016; 538(7623): 66-71. [DOI:10.1038/nature19367]
9. Alpes A, Malek S, Baron R. TRPV1 is the burner. Pain. 2025; 166(4): 717-8. [DOI:10.1097/j.pain.0000000000003542]
10. Khanizadeh A-M, Karimzadeh F. Experimental Models of Rheumatoid Arthritis: Acute and Chronic Pain. The Neuroscience Journal of Shefaye Khatam. 2017; 5(1): 98-109. [DOI:10.18869/acadpub.shefa.5.1.98]
11. Devesa I, Fernández-Ballester G, Fernandez-Carvajal A, Ferrer-Montiel A. A review of the patent literature surrounding TRPV1 modulators. Expert Opinion on Therapeutic Patents. 2025; 35(5): 477-91. [DOI:10.1080/13543776.2025.2467698]
12. González J, Palma JM, Benso B, Valdés-Muñoz E, Urra G, Ríos-Rozas SE, et al. Integrative Computational Approaches for TRPV1 Ion Channel Inhibitor Discovery: An Integrated Machine Learning, Drug Repurposing and Molecular Simulation Approach. Journal of Chemical Information and Modeling. 2025; 65(17): 8957-68. [DOI:10.1021/acs.jcim.5c00991]
13. Wallace M, Pappagallo M. Qutenza®: a capsaicin 8% patch for the management of postherpetic neuralgia. Expert Rev Neurother. 2011; 11(1): 15-27. [DOI:10.1586/ern.10.182]
14. Neuberger A, Oda M, Nikolaev YA, Nadezhdin KD, Gracheva EO, Bagriantsev SN, et al. Human TRPV1 structure and inhibition by the analgesic SB-366791. Nature communications. 2023; 14(1): 2451. [DOI:10.1038/s41467-023-38162-9]
15. Mamatova KN, Kang TM. Activation of rat transient receptor potential cation channel subfamily V member 1 channels by 2-aminoethoxydiphenyl borate. Integr Med Res. 2013; 2(3): 112-23. [DOI:10.1016/j.imr.2013.06.002]
16. Benham CD, Gunthorpe MJ, Davis JB. TRPV channels as temperature sensors. Cell Calcium. 2003; 33(5): 479-87. [DOI:10.1016/S0143-4160(03)00063-0]
17. Carballo-Villalobos A, González-Trujano M, Alvarado-Vázquez N, López-Muñoz F. Pro-inflammatory cytokines involvement in the hesperidin antihyperalgesic effects at peripheral and central levels in a neuropathic pain model. Inflammopharmacology. 2017; 25(2): 265-9. [DOI:10.1007/s10787-017-0326-3]
18. Loscalzo LM, Yow TT, Wasowski C, Chebib M, Marder M. Hesperidin induces antinociceptive effect in mice and its aglicone, hesperetin, binds to μ-opioid receptor and inhibits GIRK1/2 currents. Pharmacology Biochemistry and Behavior. 2011; 99(3): 333-41. [DOI:10.1016/j.pbb.2011.05.018]
19. Vabeiryureilai M, Lalrinzuali K, Jagetia G. Determination of anti-inflammatory and analgesic activities of a citrus bioflavanoid, hesperidin in mice. Immunochem Immunopathol: Open Access. 2015; 1(107): 2. [DOI:10.4172/2469-9756.1000107]
20. Ventura-Martinez R, Mares-Sánchez JJ, Avilés-Herrera J, Ángeles-López GE, Déciga-Campos M, González-Trujano ME, et al. Antinociceptive synergy between metamizole and hesperidin in a model of visceral pain in mice. Arch Med Res. 2021; 52(4): 389-96. [DOI:10.1016/j.arcmed.2020.12.011]
21. Pinho-Ribeiro FA, Hohmann MS, Borghi SM, Zarpelon AC, Guazelli CF, Manchope MF, et al. Protective effects of the flavonoid hesperidin methyl chalcone in inflammation and pain in mice: role of TRPV1, oxidative stress, cytokines and NF-κB. Chemico-biological interactions. 2015; 228: 88-99. [DOI:10.1016/j.cbi.2015.01.011]
22. Velázquez-González C, Cariño-Cortés R, de Lucio JAG, Ortiz MI, De la O Arciniega M, Altamirano-Báez DA, et al. Antinociceptive and anti-inflammatory activities of Geranium bellum and its isolated compounds. BMC Complementary Medicine and Therapies. 2014; 14. [DOI:10.1186/1472-6882-14-506]
23. Silva-Correa CR, Campos-Reyna JL, Villarreal-La Torre VE, Calderón-Peña AA, Blas MVG, Aspajo-Villalaz CL, et al. Potential activity of medicinal plants as pain modulators: a review. Pharmacognosy Journal. 2021; 13(1). [DOI:10.5530/pj.2021.13.35]
24. Liu Y, Chen Z-J, Fei Y, Yu X, Chen G. Investigating the therapeutic potential of epigallocatechin gallate (EGCG) for chronic pain management: Mechanisms, applications, and future perspectives. Fitoterapia. 2025: 106646. [DOI:10.1016/j.fitote.2025.106646]
25. Utugi S, Sashide Y, Takeda M. (-)-Epigallocatechin-3-Gallate Suppresses Hyperexcitability in Rat Primary Nociceptive Neurons Innervating Inflamed Tissues: A Comparison with Lidocaine. Metabolites. 2025; 15(7): 439. [DOI:10.3390/metabo15070439]
26. Ismudianto A, Airlangga PS, Putri HS. Effect of Epigallocatechin Gallate (EGCG) as an Adjuvant to Paracetamol on Pain Scale and TRPV1 Expression in a Rat Model of Neuropathic Pain. Vascular and Endovascular Review. 2025; 8(14s): 328-33.
27. Xifro X, Vidal-Sancho L, Boadas-Vaello P, Turrado C, Alberch J, Puig T, et al. Novel epigallocatechin-3-gallate (EGCG) derivative as a new therapeutic strategy for reducing neuropathic pain after chronic constriction nerve injury in mice. PLoS One. 2015; 10(4): e0123122. [DOI:10.1371/journal.pone.0123122]
28. Kurogi M, Kawai Y, Nagatomo K, Tateyama M, Kubo Y, Saitoh O. Auto-oxidation products of epigallocatechin gallate activate TRPA1 and TRPV1 in sensory neurons. Chemical senses. 2015; 40(1): 27-46. [DOI:10.1093/chemse/bju057]
29. Takahashi S, Kurogi M, Saitoh O. The diversity in sensitivity of TRPA1 and TRPV1 of various animals to polyphenols. Biomedical Research. 2021; 42(2): 43-51. [DOI:10.2220/biomedres.42.43]
30. Nalli M, Ortar G, Schiano Moriello A, Di Marzo V, De Petrocellis L. Effects of curcumin and curcumin analogues on TRP channels. Fitoterapia. 2017; 122: 126-31. [DOI:10.1016/j.fitote.2017.09.007]
31. Aggarwal R. TARGETING TRPV1 SIGNALING PATHWAY THROUGH NATURAL PRODUCTS ININFLAMMATORY CANCER. Journal of Advanced Scientific Research. 2021; 12(02 Suppl 1): 66-78.
32. Naik GG, Uniyal A, Chouhan D, Tiwari V, Sahu AN. Natural products and some semi-synthetic analogues as potential TRPV1 ligands for attenuating neuropathic pain. Current Pharmaceutical Biotechnology. 2022; 23(6): 766-86. [DOI:10.2174/1389201022666210719155931]
33. Purba AKR, Purwanto B, Zainiyah H, Gutjahr LP. Curcumin Improves the Expression of Phospholiphase C and Transient Receptor Potential Vanilloid Type 1 on Neuronal Myometrium in Dysmenorrhea Model. Sains Malaysiana. 2025; 54(2): 557-67. [DOI:10.17576/jsm-2025-5402-20]
34. Wang X, Zhang G, Qiao Y, Feng C, Zhao X. Crocetin attenuates spared nerve injury-induced neuropathic pain in mice. Journal of pharmacological sciences. 2017; 135(4): 141-7. [DOI:10.1016/j.jphs.2017.08.007]
35. Erfanparast A, Tamaddonfard E, Henareh-Chareh F, editors. Central H2 histaminergic and alpha-2 adrenergic receptors involvement in crocetin-induced antinociception in orofacial formalin pain in rats. Veterinary Research Forum; 2020.
36. Abdel-Salam OM, Mózsik G. Capsaicin, the vanilloid receptor TRPV1 agonist in neuroprotection: mechanisms involved and significance. Neurochemical Research. 2023; 48(11): 3296-315. [DOI:10.1007/s11064-023-03983-z]
37. Szallasi A. Targeting TRPV1 for cancer pain relief: can it work? Cancers. 2024; 16(3): 648. [DOI:10.3390/cancers16030648]
38. Chung M-K, Campbell JN. Use of capsaicin to treat pain: mechanistic and therapeutic considerations. Pharmaceuticals. 2016; 9(4): 66. [DOI:10.3390/ph9040066]
39. Heydarian S. Drug Nanocarriers as a Potential Therapeutic Strategy in Glioblastoma Multiforme. The Neuroscience Journal of Shefaye Khatam. 2023; 11(3): 110-26. [DOI:10.61186/shefa.11.3.110]
40. Tondro G, Rajabzade G, Mohammadi A, Moradi H, Sahab Negah S. Anti-Inflammatory Effects of Nano- Curcumin on a Glioblastoma Cell Line. The Neuroscience Journal of Shefaye Khatam. 2022; 10(3): 48-56. [DOI:10.52547/shefa.10.3.48]
41. Sadoughi D, Khayatzadeh J. Effect of Curcumin on Hippocampal Levels of Brain-Derived Neurotrophic Factor and Serum Levels of Inflammatory Cytokines in Rat Model for Alzheimer's Disease. The Neuroscience Journal of Shefaye Khatam. 2018; 6(1): 1-9. [DOI:10.29252/shefa.6.1.1]


XML   Persian Abstract   Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Back to the articles list Back to browse issues page
مجله علوم اعصاب شفای خاتم The Neuroscience Journal of Shefaye Khatam
Persian site map - English site map - Created in 0.1 seconds with 47 queries by YEKTAWEB 4784